Your browser doesn't support javascript.
loading
An imaging-based artificial intelligence model for non-invasive grading of hepatic venous pressure gradient in cirrhotic portal hypertension.
Yu, Qian; Huang, Yifei; Li, Xiaoguo; Pavlides, Michael; Liu, Dengxiang; Luo, Hongwu; Ding, Huiguo; An, Weimin; Liu, Fuquan; Zuo, Changzeng; Lu, Chunqiang; Tang, Tianyu; Wang, Yuancheng; Huang, Shan; Liu, Chuan; Zheng, Tianlei; Kang, Ning; Liu, Changchun; Wang, Jitao; Akçalar, Seray; Çelebioglu, Emrecan; Üstüner, Evren; Bilgiç, Sadik; Fang, Qu; Fu, Chi-Cheng; Zhang, Ruiping; Wang, Chengyan; Wei, Jingwei; Tian, Jie; Örmeci, Necati; Ellik, Zeynep; Asiller, Özgün Ömer; Ju, Shenghong; Qi, Xiaolong.
Afiliação
  • Yu Q; Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
  • Huang Y; CHESS Center, Institute of Portal Hypertension, First Hospital of Lanzhou University, Lanzhou, China.
  • Li X; CHESS Center, Institute of Portal Hypertension, First Hospital of Lanzhou University, Lanzhou, China.
  • Pavlides M; Radcliffe Department of Medicine, Oxford Centre for Magnetic Resonance Research, John Radcliffe Hospital, University of Oxford, Oxford, UK.
  • Liu D; CHESS Working Party, Xingtai People's Hospital, Xingtai, China.
  • Luo H; Department of General Surgery, Third Xiangya Hospital of Central South University, Changsha, China.
  • Ding H; Department of Gastroenterology and Hepatology, Beijing You'an Hospital, Capital Medical University, Beijing, China.
  • An W; Department of Radiology, Fifth Medical Center of PLA General Hospital, Beijing, China.
  • Liu F; Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
  • Zuo C; CHESS Working Party, Xingtai People's Hospital, Xingtai, China.
  • Lu C; Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
  • Tang T; Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
  • Wang Y; Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
  • Huang S; Department of Radiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.
  • Liu C; CHESS Center, Institute of Portal Hypertension, First Hospital of Lanzhou University, Lanzhou, China.
  • Zheng T; CHESS Center, Institute of Portal Hypertension, First Hospital of Lanzhou University, Lanzhou, China.
  • Kang N; CHESS Center, Institute of Portal Hypertension, First Hospital of Lanzhou University, Lanzhou, China.
  • Liu C; Department of Radiology, Fifth Medical Center of PLA General Hospital, Beijing, China.
  • Wang J; CHESS Working Party, Xingtai People's Hospital, Xingtai, China.
  • Akçalar S; Department of Radiology, Ankara University School of Medicine, Ankara, Turkey.
  • Çelebioglu E; Department of Radiology, Ankara University School of Medicine, Ankara, Turkey.
  • Üstüner E; Department of Radiology, Ankara University School of Medicine, Ankara, Turkey.
  • Bilgiç S; Department of Radiology, Ankara University School of Medicine, Ankara, Turkey.
  • Fang Q; Shanghai Aitrox Technology Corporation, Shanghai, China.
  • Fu CC; Shanghai Aitrox Technology Corporation, Shanghai, China.
  • Zhang R; Department of Radiology, Shanxi Bethune Hospital, Third Hospital of Shanxi Medical University, Shanxi, China.
  • Wang C; Human Phenome Institute, Fudan University, Shanghai, China.
  • Wei J; Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
  • Tian J; Beijing Key Laboratory of Molecular Imaging, Beijing, China.
  • Örmeci N; Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China.
  • Ellik Z; Beijing Key Laboratory of Molecular Imaging, Beijing, China.
  • Asiller ÖÖ; Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey.
  • Ju S; Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey.
  • Qi X; Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey.
Cell Rep Med ; 3(3): 100563, 2022 03 15.
Article em En | MEDLINE | ID: mdl-35492878
ABSTRACT
The hepatic venous pressure gradient (HVPG) is the gold standard for cirrhotic portal hypertension (PHT), but it is invasive and specialized. Alternative non-invasive techniques are needed to assess the hepatic venous pressure gradient (HVPG). Here, we develop an auto-machine-learning CT radiomics HVPG quantitative model (aHVPG), and then we validate the model in internal and external test datasets by the area under the receiver operating characteristic curves (AUCs) for HVPG stages (≥10, ≥12, ≥16, and ≥20 mm Hg) and compare the model with imaging- and serum-based tools. The final aHVPG model achieves AUCs over 0.80 and outperforms other non-invasive tools for assessing HVPG. The model shows performance improvement in identifying the severity of PHT, which may help non-invasive HVPG primary prophylaxis when transjugular HVPG measurements are not available.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Hipertensão Portal Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Hipertensão Portal Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Cell Rep Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
...